|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 38/00 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 29/00 | (2006.01) | ||
| C07K 7/00 | (2006.01) | ||
| C07K 14/515 | (2006.01) | ||
| C07K 16/22 | (2006.01) | ||
| C07K 19/00 | (2006.01) |
| (11) | Number of the document | 1615952 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04759343.9 |
| Date of filing the European patent application | 2004-04-08 | |
| (97) | Date of publication of the European application | 2006-01-18 |
| (45) | Date of publication and mention of the grant of the patent | 2011-11-02 |
| (46) | Date of publication of the claims translation | 2012-01-25 |
| (86) | Number | PCT/US2004/010989 |
| Date | 2004-04-08 |
| (87) | Number | WO 2004/092215 |
| Date | 2004-10-28 |
| (30) | Number | Date | Country code |
| 410998 | 2003-04-09 | US |
| (72) |
OLINER, Jonathan, Daniel, US
MIN, Hosung, US
|
| (73) |
AMGEN INC.,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Uždegiminių ligų gydymo būdai, naudojant prie žmogaus angiopoetino-2 specifiškai prisirišančius agentus |
| METHODS OF TREATMENT OF INFLAMMATORY DISEASES USING SPECIFIC BINDING AGENTS OF HUMAN ANGIOPOIETIN-2 |
| Payment date | Validity (years) | Amount | |
| 2022-03-22 | 19 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-04-08 |